2019
DOI: 10.1021/acs.cgd.8b01881
|View full text |Cite
|
Sign up to set email alerts
|

Olanzapine Form IV: Discovery of a New Polymorphic Form Enabled by Computed Crystal Energy Landscapes

Abstract: Olanzapine is a polymorphic drug molecule that has been extensively studied, with over 60 structures reported in the Cambridge Structural Database. All anhydrous and solvated forms of olanzapine known to date contain the SC0 dimer packing motif. In this study, a new screening approach was adopted involving heat-induced forced crystallization from a polymer-based molecular dispersion of olanzapine. Simultaneous differential scanning calorimetry-powder X-ray diffraction (DSC-PXRD) was used to heat the amorphous … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
53
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 37 publications
(56 citation statements)
references
References 40 publications
3
53
0
Order By: Relevance
“…Alas, some publications (Tiwari et al, 2007), as well as patent claims to a new OZPN form III, overlooked or ignored our 2003 report identifying a third polymorph (III) in mixture with form II, and while the existence of form III was recognized in a 2011 publication reporting a newly discovered form IV (Thakuria & Nangia, 2011), excellent agreement between the PXRD pattern simulated from the single-crystal structure disclosed in this report and the experimental powder pattern of form II quickly disproved the claim of a new polymorph. Only recently has a fourth OZPN polymorph, form IV, been confirmed (Askin et al, 2019), and as will be discussed later, its discovery would wait many years for the right heterogeneous nucleation experiment to be conducted.…”
Section: Polymorphs Patents Perversitymentioning
confidence: 99%
See 1 more Smart Citation
“…Alas, some publications (Tiwari et al, 2007), as well as patent claims to a new OZPN form III, overlooked or ignored our 2003 report identifying a third polymorph (III) in mixture with form II, and while the existence of form III was recognized in a 2011 publication reporting a newly discovered form IV (Thakuria & Nangia, 2011), excellent agreement between the PXRD pattern simulated from the single-crystal structure disclosed in this report and the experimental powder pattern of form II quickly disproved the claim of a new polymorph. Only recently has a fourth OZPN polymorph, form IV, been confirmed (Askin et al, 2019), and as will be discussed later, its discovery would wait many years for the right heterogeneous nucleation experiment to be conducted.…”
Section: Polymorphs Patents Perversitymentioning
confidence: 99%
“…With a growing number of reports of predicted crystal structures having later been found (Braun et al, 2014(Braun et al, , 2016Arlin et al, 2011;Neumann et al, 2015) and the potential to crystallize a more stable polymorph, many attempts, all unsuccessful, were made to target nondimer structures of OZPN (Bhardwaj et al, 2013). Eventually, a fourth polymorph (IV), not based on OZPN dimers, would be discovered using a novel screening approach: heat-induced crystallization from an amorphous polyvinylpyrrolidone (PVP) based molecular dispersion (Askin et al, 2019). The prediction of more stable OZPN crystal structures prompted further exploration of crystallization conditions which ultimately led to the discovery of form IV.…”
Section: Landscapes Leads Learningmentioning
confidence: 99%
“…[7] Most recently,w e employed the DSC-XRD platform with crystal structure prediction work and were able to identify and solvet he structure of an ew polymorph of olanzapine. [8] Herein, we extendt he DSC-XRD approach to explore the fabrication of co-crystals by thermalm ethods. Understanding these processes is important, becausef or industriala pplications co-crystals are most likely to be preparedu sing hot melt extrusion (HME), ac ontinuous manufacturinga pproach which appliesh eat energy to an intimate mixture of the co-formers to generateaco-crystal.…”
Section: Introductionmentioning
confidence: 99%
“…This approach has led to enhanced understanding of phase transitions in glutaric acid and sulfathiazole, [5] carbamazepine and dihydrocarbamazapine, [6] and paracetamol [7] . Most recently, we employed the DSC‐XRD platform with crystal structure prediction work and were able to identify and solve the structure of a new polymorph of olanzapine [8] …”
Section: Introductionmentioning
confidence: 99%
“…The polymer may form an intrinsic part of a co-crystal structure 1 or it may simply act as a template for crystal growth in the synthesis of new polymorphs. 2 Alternatively, the polymer may act as a template for the formation of novel supramolecular structures. To the best of our knowledge, the ammonium pentaborate -poly(ethylene-glycol) templated polymer-inclusion compound reported here is the only boratebased inclusion compound to host organic guest molecules.…”
mentioning
confidence: 99%